<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02314468</url>
  </required_header>
  <id_info>
    <org_study_id>2013/724</org_study_id>
    <nct_id>NCT02314468</nct_id>
  </id_info>
  <brief_title>Negative Pressure Wound Therapy and Allogeneic Human Skin Grafts for Wound Bed Preparation</brief_title>
  <acronym>NPWTvsGPA</acronym>
  <official_title>Comparative Study of Negative Pressure Wound Therapy and Allogeneic Human Skin Grafts for Wound Bed Preparation in Necrotising Soft Tissue Infections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Ghent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Ghent</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Introduction Necrotising soft tissue infections (NSTI) incorporate a spectrum of pathologies,&#xD;
      all characterized by an infectious state, typically arising after a penetrating trauma or a&#xD;
      surgical procedure and an expeditious spreading of necrosis throughout the soft tissues of&#xD;
      the body. It is a rare, life-threatening and devastating infection defined by a necrosis of&#xD;
      fascia, subcutaneous tissues and skin. Aggressive surgical debridement to remove all necrotic&#xD;
      tissue and define the extent of the disease is still the mainstay of correct treatment of&#xD;
      NSTI.&#xD;
&#xD;
      Both negative pressure wound therapy (NPWT) and the application of allograft skin to debrided&#xD;
      areas, are documented options for wound bed preparation which are standard in the university&#xD;
      hospital of Gent.&#xD;
&#xD;
      NPWT is a technique for wound bed preparation involving the controlled application of&#xD;
      sub-atmospheric pressure to the local wound environment, using a sealed wound dressing&#xD;
      connected to a vacuum pump. Mechanisms of action attributed to NPWT include an increase in&#xD;
      blood flow, promotion of angiogenesis, reduction in wound surface area, positive modulation&#xD;
      of the inhibitory contents of wound fluid, induction of cell proliferation, reduction of&#xD;
      edema, and bacterial clearance.&#xD;
&#xD;
      Allograft skin or cadaveric skin possesses many of the ideal properties of biologic&#xD;
      dressings, and plays a major role in the surgical management of extensive wounds when&#xD;
      autologous tissue may not be immediately available. It reduces evaporative water loss and the&#xD;
      drainage of protein-rich fluids, prevents wound desiccation, and suppresses microbial&#xD;
      proliferation. Wound pain is lessened and the allograft restores a physiologic barrier at the&#xD;
      wound surface. Enhancing revascularization, and thereby creating a viable wound bed before&#xD;
      final reconstruction, is perceived as one of the most important features of allografting.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study objectives This study will compare negative pressure wound therapy versus cadaveric&#xD;
      skin as treatment options for wound bed preparation in wounds resulting from necrotising soft&#xD;
      tissue infection.&#xD;
&#xD;
      Methodology One arm includes a NPWT system that is used in conjunction with gauze or foam&#xD;
      dressings. Dressing changes normally will be carried out twice a week unless otherwise&#xD;
      indicated by the wound condition, the patients clinical presentation or a seal broken beyond&#xD;
      repair. NPWT wound bed preparation will be ended when two experienced plastic surgeons&#xD;
      consider the wound bed suitable for autografting. (Endpoint) The second arm includes&#xD;
      application of cadaveric skin. The allografts normally will be changed every seven to ten&#xD;
      days or earlier depending on adhesion of the allograft to the wound bed. In practice, the&#xD;
      ability of the allograft to adhere to the wound bed has a diagnostic value, referred to as a&#xD;
      'take-test'. If the allograft does not adhere, one must consider an infection or non-viable&#xD;
      wound surface. If the allograft adheres to the wound bed and adequate granulation tissue is&#xD;
      suspected underneath, then the wound bed is suitable for autografting. (Endpoint)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">October 2016</completion_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of wound bed preparation until autografting.</measure>
    <time_frame>After 3 days</time_frame>
    <description>WHAT software, clinical assessment by plastic surgeon, Laser Doppler Imaging scan.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain assessment until autografting.</measure>
    <time_frame>After 3 days</time_frame>
    <description>Numerical pain scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ease of use until autografting.</measure>
    <time_frame>After 3 days</time_frame>
    <description>Numerical scale for ease of use.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost utility until autografting.</measure>
    <time_frame>After 3 days</time_frame>
    <description>Cost of material.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Necrotizing Soft Tissue Infection</condition>
  <arm_group>
    <arm_group_label>negative pressure wound therapy (NPWT)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>negative pressure wound therapy (NPWT)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Glycerol Preserved Allografts (GPA)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Glycerol Preserved Allografts (GPA)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Negative pressure wound therapy</intervention_name>
    <description>NPWT changed twice a week.</description>
    <arm_group_label>negative pressure wound therapy (NPWT)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Glycerol Preserved Allografts (GPA)</intervention_name>
    <description>GPA changed every 7 to 10 days.</description>
    <arm_group_label>Glycerol Preserved Allografts (GPA)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Necrotising soft tissue infection&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        None specific&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stan Monstrey, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Ghent</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kevin Peters, MD</last_name>
    <email>Kevin.Peters@ugent.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Ghent</name>
      <address>
        <city>Ghent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kevin Peters, MD</last_name>
      <email>Kevin.Peters@ugent.be</email>
    </contact>
    <investigator>
      <last_name>Stan Monstrey, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kevin Peters, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <link>
    <url>http://www.uzgent.be</url>
    <description>website hospital</description>
  </link>
  <verification_date>December 2014</verification_date>
  <study_first_submitted>September 30, 2013</study_first_submitted>
  <study_first_submitted_qc>December 8, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 11, 2014</study_first_posted>
  <last_update_submitted>December 8, 2014</last_update_submitted>
  <last_update_submitted_qc>December 8, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 11, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Soft Tissue Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glycerol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

